Summary by Moomoo AI
PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (PLATINUM PHARMACEUTICALS-B) FILED ITS LATEST SECURITIES MONTHLY CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON MARCH 6, 2024, COVERING THE SITUATION AS OF FEBRUARY 29, 2024. The report shows that the company's regulated/registered share capital remained unchanged during the month, with a total deposit of $500,000, corresponding to 20,000,000,000 shares of ordinary shares with a face value of $0.000025 per share. In addition, the Company's stock option plan remained unchanged, with 39,250,950 share options outstanding at the end of the month, and no new shares were issued as a result of the exercise of options. The report also noted that the company repurchased 1,750,000 shares of ordinary shares on June 8, 2023, but the total increase in ordinary shares during the month was zero. The Company confirms that all issues of securities have been formally authorized by the Board of Directors and comply with the relevant legal requirements.